PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS RALOXIFENE FOR TREATING OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN IN THE UNITED STATES
May 1, 2011, 00:00
10.1016/j.jval.2011.02.719
https://www.valueinhealthjournal.com/article/S1098-3015(11)00858-8/fulltext
Title :
PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS RALOXIFENE FOR TREATING OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN IN THE UNITED STATES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00858-8&doi=10.1016/j.jval.2011.02.719
First page :
A129
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
177